Tuesday, April 23, 2024
Advertisement
  • us regulator imposes conditions on sun s ranbaxy acquisition

    US regulator imposes conditions on Sun's Ranbaxy acquisition

    Jan 31, 2015, 07:13 AM IST

    Washington: An American federal trade regulator today imposed conditions on Sun Pharmaceuticals' acquisition of Ranbaxy on the grounds that the USD 4 billion proposed deal would likely be anti-competitive.The Federal Trade Commission (FTC) said pharmaceutical

Advertisement
Advertisement
Advertisement
Advertisement